141 related articles for article (PubMed ID: 19089994)
21. [PTX1 in nasopharyngeal carcinoma by RNAi technology].
Zhou W; Li H; Feng XL; Wang L; Zhu B; Li H; Yao KT; Ren CP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):235-40. PubMed ID: 17478929
[TBL] [Abstract][Full Text] [Related]
22. TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression.
Ruptier C; De Gaspéris A; Ansieau S; Granjon A; Tanière P; Lafosse I; Shi H; Petitjean A; Taranchon-Clermont E; Tribollet V; Voeltzel T; Scoazec JY; Maguer-Satta V; Puisieux A; Hainaut P; Cavard C; Caron de Fromentel C
Oncogene; 2011 Nov; 30(46):4656-65. PubMed ID: 21643019
[TBL] [Abstract][Full Text] [Related]
23. Role of the RARRES1 gene in nasopharyngeal carcinoma.
Kwok WK; Pang JC; Lo KW; Ng HK
Cancer Genet Cytogenet; 2009 Oct; 194(1):58-64. PubMed ID: 19737656
[TBL] [Abstract][Full Text] [Related]
24. p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms.
Okuyama T; Kurata S; Tomimori Y; Fukunishi N; Sato S; Osada M; Tsukinoki K; Jin HF; Yamashita A; Ito M; Kobayashi S; Hata RI; Ikawa Y; Katoh I
Oncogene; 2008 Jan; 27(3):308-17. PubMed ID: 17637751
[TBL] [Abstract][Full Text] [Related]
25. Gleevec suppresses p63 expression in head and neck squamous cell carcinoma despite p63 activation by DNA-damaging agents.
Ongkeko WM; An Y; Chu TS; Aguilera J; Dang CL; Wang-Rodriguez J
Laryngoscope; 2006 Aug; 116(8):1390-6. PubMed ID: 16885742
[TBL] [Abstract][Full Text] [Related]
26. [Effect of JIP on the proliferation and apoptosis of nasopharyngeal carcinoma cells].
Hu Z; Tao YG; Yang LF; Tang FQ; Luo FJ; Zeng L; Yi W; Cao Y
Ai Zheng; 2002 Nov; 21(11):1182-6. PubMed ID: 12526212
[TBL] [Abstract][Full Text] [Related]
27. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract][Full Text] [Related]
28. DeltaNp63 plays an anti-apoptotic role in ventral bladder development.
Cheng W; Jacobs WB; Zhang JJ; Moro A; Park JH; Kushida M; Qiu W; Mills AA; Kim PC
Development; 2006 Dec; 133(23):4783-92. PubMed ID: 17079275
[TBL] [Abstract][Full Text] [Related]
29. Regulation of RASSF1A in nasopharyngeal cells and its response to UV irradiation.
Lee VH; Chow BK; Lo KW; Chow LS; Man C; Tsao SW; Lee LT
Gene; 2009 Aug; 443(1-2):55-63. PubMed ID: 19450668
[TBL] [Abstract][Full Text] [Related]
30. Regulation of p63 expression in primary and immortalized nasopharyngeal epithelial cells.
Yip YL; Tsao SW
Int J Oncol; 2008 Oct; 33(4):713-24. PubMed ID: 18813784
[TBL] [Abstract][Full Text] [Related]
31. KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells.
Nakamura S; Okinaka K; Hirano I; Ono T; Sugimoto Y; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
Leuk Res; 2008 Sep; 32(9):1358-65. PubMed ID: 18384876
[TBL] [Abstract][Full Text] [Related]
32. Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
Wong AM; Kong KL; Chen L; Liu M; Wong AM; Zhu C; Tsang JW; Guan XY
Int J Cancer; 2013 Nov; 133(10):2284-95. PubMed ID: 23649311
[TBL] [Abstract][Full Text] [Related]
33. siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
Liu H; Wang M; Diao S; Rao Q; Zhang X; Xing H; Wang J
Leuk Res; 2009 Sep; 33(9):1243-8. PubMed ID: 19299014
[TBL] [Abstract][Full Text] [Related]
34. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
[TBL] [Abstract][Full Text] [Related]
35. G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization.
Liu SC; Jen YM; Jiang SS; Chang JL; Hsiung CA; Wang CH; Juang JL
Cancer Res; 2009 Aug; 69(15):6122-30. PubMed ID: 19602597
[TBL] [Abstract][Full Text] [Related]
36. Characterization of ZNF23, a KRAB-containing protein that is downregulated in human cancers and inhibits cell cycle progression.
Huang C; Jia Y; Yang S; Chen B; Sun H; Shen F; Wang Y
Exp Cell Res; 2007 Jan; 313(2):254-63. PubMed ID: 17137575
[TBL] [Abstract][Full Text] [Related]
37. Overproduction of cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: implication for therapy.
Huang XM; Dai CB; Mou ZL; Wang LJ; Wen WP; Lin SG; Xu G; Li HB
Cancer Lett; 2009 Jun; 279(1):47-56. PubMed ID: 19203829
[TBL] [Abstract][Full Text] [Related]
38. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
39. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63.
Chow SE; Chang YL; Chuang SF; Wang JS
Cancer Chemother Pharmacol; 2011 Oct; 68(4):835-45. PubMed ID: 21207227
[TBL] [Abstract][Full Text] [Related]
40. The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Dev Neurobiol; 2012 Jun; 72(6):821-42. PubMed ID: 22076965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
